Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beta Bionics, Inc.

19.31
+0.23001.21%
Volume:258.99K
Turnover:4.90M
Market Cap:837.21M
PE:-3.41
High:19.82
Open:18.80
Low:18.43
Close:19.08
Loading ...
OverviewCompanyNewsFilings

Palantir initiated, Roku upgraded: Wall Street’s top analyst calls

TipRanks
·
21 Feb

Ladenburg Thalmann Initiates Beta Bionics at Buy With $31 Price Target

MT Newswires Live
·
20 Feb

Beta Bionics initiated with a Neutral at Baird

TIPRANKS
·
20 Feb

Major Shareholder Makes Bold Move with Huge Stock Purchase

TIPRANKS
·
04 Feb

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire
·
01 Feb

Oil company Infinity Natural Resources debuts IPO amid deregulation push

Dow Jones
·
31 Jan

Stock Track | Beta Bionics Soars 41% on Nasdaq Debut Amid Strong IPO Demand

Stock Track
·
31 Jan

Beta Bionics Shares Rise in Nasdaq Debut

MT Newswires Live
·
31 Jan

BRIEF-Beta Bionics Priced IPO At $17.00 Per Share

Reuters
·
30 Jan

Beta Bionics raises $204 mln in upsized US IPO

Reuters
·
30 Jan

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

GlobeNewswire
·
30 Jan

Analyst Rate

Buy
Buy
75.00%
Hold
25.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
May 06, 2025 Post Market
Financial Report Announcement
Mar 25, 2025 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-11.94
Current
-11.50
Sector Average
34.83%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-11.94
Maximum
-8.41
+1 STD
-8.02
Minimum
-18.26
-1 STD
-14.98
Average
-11.50

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.